Business
UBS, Minters help Arrotex in $205m McPherson’s bid – The Australian Financial Review
Rich Lister Ruffy Geminder has got a fight on his hands at ASX-listed beauty company and takeover target McPherson’s.
And while McPhersons board said Gallins offer undervalued the company, it said it would give Arrotex access to due diligence information and progress discussions, with a view to developing a transaction to put to shareholders.
Arrotex was formed in 2019, following the merger of Arrow Pharmaceuticals and Apotex Australia. The company supplies generic pharmaceuticals, over the counter products and vitamins to pharmacies around the country.
Meanwhile, McPhersons supplies health, wellness and beauty…
Continue Reading